Program at a Glance
Conference Session
Open Session
Company Presentation
| Innovative Biotechnology |
Bio-Convergence Technology |
Business & Development |
| May 7 (Wed) | |||
| Time | Rm.401 | Rm.307 | Rm.308 |
| 09:00~12:00 |
Keynote Speech (10:30~11:20) |
||
| 13:00~17:00 |
AI-based New Drug Development
S1.
 13:30~17:00
AI-Driven Drug Development: A Journey Towards Viable Solutions
|
Brain-Computer Interface
S2.
13:30~17:00
The Great Connection of the 21st Century: Brain-Computer Interface (BCI)
|
Regenerative Medicine
S3.
13:30~17:00
Advanced Regenerative Medicine: The Beginning of a New Medical Paradigm
|
| May 8 (Thu) | |||
| Time | Rm.401 | Rm.307 | Rm.308 |
| 09:00~12:00 |
Open Innovation - Pharmaceuticals
S4.
09:30~11:40
The Key to Innovation: Global Open Innovation Strategy
|
Global Bio Governance
S6.
09:30~11:40
Global Bio Governance 2025: Change and Future
|
Regenerative Medicine
S8.
09:30~11:45
Strengthening the Competitiveness of Domestic Regenerative Medicine by Discovering Outstanding New Technologies for Cutting-edge Regenerative Medicine
|
| 12:00~13:00 |
Luncheon Session |
||
|
Global BIO Connection ①
|
Global BIO Connection ②
|
||
| 13:00~17:00 |
New Drug Modality
S5.
13:00~17:00
The Rise of New Modalities: A Game Changer in Drug Development
|
Global Bio Governance
S7.
13:30~16:00
Strategies for Sustainable Global Biopharmaceutical Approval
|
Space Biotechnology
S9.
13:30~17:00
Life Sciences in Space: A New Horizon for Biohealth
|
| May 9 (Fri) | |||
| Time | Rm.401 | Rm.307 | Rm.308 |
| 09:00~12:00 |
Anti-aging and Rejuvenation
S10.
09:30~12:00
Innovative Aging Control Technologies: Immunity, Diagnostics, and Evaluation Platforms
|
Clinical Trial
S12.
09:30~12:00
Evolving Global Trends and New Technologies in Clinical Trials
|
Preclinical - Alternative Toxicology Solutions
S14.
09:30~15:35
Alternative Toxicity Testing: Our Choice and Challenges for Leading the Future Bio Market
|
| 13:00~17:00 |
Anti-aging and Rejuvenation
S11.
13:30~15:30
The Present and Future of Reverse-aging Technologies
|
Bio-Digital Convergence Technology
S13.
13:00~16:00
Beyond Innovation: The Path to Successful Clinical Adoption and Market Expansion of Digital Therapy
|
|
|
|
Day1
5/7(Wed)
|
OS1.
Golden Triangle Open Innovation: Korea-UK-Japan Trilateral Collaboration in Life-Science -Digital -Health
13:00~17:30
|
OS2.
Workshop on Strategic Collaboration between Korea and Saudi Arabia: Propelling the Growth of Global Biohubs
13:00~17:30
|
OS3.
Healthy Aging: Advancing Science for Longevity
13:00~17:00
|
OS4.
K-BIC Venture Cafe
12:00~13:00
|
OS5.
2025 Spring Bio-health Policy and Research Forum
14:00~15:40
|
OS6.
Advancing Biopharmaceutical Research, Manufacturing, and Workforce Development
15:10~17:00
|
|
|
Day2
5/8(Thu)
|
OS9.
Canada’s Thriving Life Sciences: Innovation and Collaboration from British Columbia to Beyond
13:30~14:20
OS10.
Global ATMP Forum
14:30~16:35
|
OS11.
2025 Joint Session on Regenerative Medicine Institution Designation and Regenerative Medical Treatment System
14:00~16:15
|
OS12.
Current Status and Strategy of BioBigData.Korea
13:30~16:50
|
OS13.
Global Pharma Supply Chain from Industry Perspective
13:40~17:00
|
OS14.
2025 BioHealth Commercialization Promising Technology Briefing Session
14:00~16:05
|
||
|
Day3
5/9(Fri)
|
OS15.
AI Research Cases Utilizing Healthcare Data from the National Institute of Health
09:30~11:30
|
||||||
|
| Time | Rm.317 | Rm.317 | Rm.317 |
| 10:00~11:00 | AMGEN |
MSD |
|
| 11:00~11:10 | Break |
||
| 11:10~12:10 | Sysmex |
||
| 12:10~13:30 | Lunch Break |
||
| 13:30~14:30 |
Johnson & Johnson
* Registration begins at 13:30* Session begins at 14:00 |
ST PHARM |
|
| 14:30~14:40 | Break |
||
| 14:40~15:40 | ACROBiosystems |
||
| 15:40~15:50 | |||
| 15:50~16:50 | |||
BIO KOREA 2025 SPONSOR
BIO KOREA 2025 PARTNERS
